Relmada Therapeutics IncNASDAQ:RLMD
- LAST PRICE3.3700
- TODAY'S CHANGE (%)0.0900 (2.7439%)
- Bid / Lots3.2500/ 1
- Ask / Lots3.5500/ 2
- Open / Previous Close3.2700 / 3.2800
- Day Range
- 52 Week Range
- Volume168,690
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RLMD |
|---|---|---|
| 09:32 ET | 4282 | 3.27 |
| 09:36 ET | 1000 | 3.305 |
| 09:38 ET | 4706 | 3.2301 |
| 09:39 ET | 7729 | 3.2 |
| 09:41 ET | 2174 | 3.185 |
| 09:43 ET | 1200 | 3.2441 |
| 09:52 ET | 1582 | 3.27 |
| 09:54 ET | 100 | 3.3 |
| 09:56 ET | 100 | 3.3 |
| 09:57 ET | 100 | 3.3 |
| 09:59 ET | 100 | 3.3 |
| 10:01 ET | 200 | 3.265 |
| 10:03 ET | 400 | 3.28 |
| 10:08 ET | 4273 | 3.395 |
| 10:10 ET | 600 | 3.43 |
| 10:12 ET | 300 | 3.37 |
| 10:14 ET | 100 | 3.43 |
| 10:15 ET | 450 | 3.4048 |
| 10:17 ET | 300 | 3.4 |
| 10:19 ET | 700 | 3.4 |
| 10:21 ET | 300 | 3.4 |
| 10:24 ET | 550 | 3.43 |
| 10:26 ET | 200 | 3.46 |
| 10:28 ET | 12175 | 3.38 |
| 10:32 ET | 1200 | 3.48 |
| 10:35 ET | 100 | 3.46 |
| 10:37 ET | 1900 | 3.42 |
| 10:39 ET | 300 | 3.42 |
| 10:42 ET | 100 | 3.45 |
| 10:46 ET | 800 | 3.43 |
| 10:48 ET | 100 | 3.45 |
| 10:55 ET | 100 | 3.44 |
| 11:00 ET | 200 | 3.44 |
| 11:04 ET | 300 | 3.405 |
| 11:08 ET | 1000 | 3.4338 |
| 11:09 ET | 100 | 3.45 |
| 11:13 ET | 100 | 3.435 |
| 11:15 ET | 300 | 3.41 |
| 11:20 ET | 936 | 3.445 |
| 11:22 ET | 800 | 3.45 |
| 11:24 ET | 100 | 3.46 |
| 11:31 ET | 100 | 3.45 |
| 11:33 ET | 471 | 3.44 |
| 11:36 ET | 100 | 3.44 |
| 11:40 ET | 100 | 3.44 |
| 11:42 ET | 100 | 3.415 |
| 11:44 ET | 100 | 3.44 |
| 11:47 ET | 100 | 3.44 |
| 11:49 ET | 1500 | 3.46 |
| 11:51 ET | 523 | 3.46 |
| 11:54 ET | 400 | 3.4501 |
| 11:56 ET | 200 | 3.46 |
| 12:00 ET | 1300 | 3.43 |
| 12:02 ET | 100 | 3.43 |
| 12:05 ET | 400 | 3.44 |
| 12:09 ET | 100 | 3.44 |
| 12:16 ET | 100 | 3.45 |
| 12:20 ET | 600 | 3.43 |
| 12:23 ET | 202 | 3.45 |
| 12:27 ET | 611 | 3.45 |
| 12:32 ET | 200 | 3.45 |
| 12:34 ET | 200 | 3.45 |
| 12:38 ET | 100 | 3.46 |
| 12:39 ET | 900 | 3.44 |
| 12:41 ET | 100 | 3.43 |
| 12:45 ET | 100 | 3.42 |
| 12:48 ET | 100 | 3.425 |
| 12:50 ET | 300 | 3.402 |
| 12:57 ET | 200 | 3.44 |
| 01:03 ET | 200 | 3.43 |
| 01:10 ET | 300 | 3.41 |
| 01:12 ET | 780 | 3.43 |
| 01:19 ET | 100 | 3.432 |
| 01:21 ET | 300 | 3.45 |
| 01:24 ET | 808 | 3.45 |
| 01:30 ET | 100 | 3.46 |
| 01:42 ET | 413 | 3.45 |
| 01:50 ET | 287 | 3.44 |
| 01:51 ET | 200 | 3.44 |
| 01:55 ET | 5850 | 3.39 |
| 01:57 ET | 100 | 3.39 |
| 02:00 ET | 1700 | 3.37 |
| 02:09 ET | 300 | 3.364 |
| 02:13 ET | 100 | 3.365 |
| 02:20 ET | 300 | 3.352 |
| 02:26 ET | 112 | 3.365 |
| 02:31 ET | 300 | 3.335 |
| 02:42 ET | 300 | 3.33 |
| 02:44 ET | 100 | 3.33 |
| 02:45 ET | 600 | 3.34 |
| 02:49 ET | 200 | 3.36 |
| 03:00 ET | 300 | 3.354 |
| 03:02 ET | 300 | 3.37 |
| 03:07 ET | 500 | 3.42 |
| 03:12 ET | 400 | 3.442 |
| 03:14 ET | 500 | 3.46 |
| 03:18 ET | 100 | 3.46 |
| 03:23 ET | 12200 | 3.39 |
| 03:27 ET | 1400 | 3.39 |
| 03:30 ET | 6751 | 3.4 |
| 03:38 ET | 100 | 3.39 |
| 03:39 ET | 100 | 3.385 |
| 03:41 ET | 400 | 3.38 |
| 03:43 ET | 200 | 3.3891 |
| 03:45 ET | 300 | 3.35 |
| 03:48 ET | 100 | 3.35 |
| 03:50 ET | 2159 | 3.375 |
| 03:52 ET | 200 | 3.41 |
| 03:56 ET | 700 | 3.4 |
| 03:57 ET | 600 | 3.395 |
| 03:59 ET | 9776 | 3.37 |
Sep 17, 2024
DJ Relmada Therapeutics Raised to Buy From Hold by Jefferies, from 8:56AM ET on Tuesday Sep 17, 2024 by Dow Jones
8:56AM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm, from 9:36PM ET on Monday Sep 16, 2024 by Dow Jones
9:36PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 5, 2024
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm, from 9:29AM ET on Thursday Sep 05, 2024 by Dow Jones
9:29AM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Relmada Therapeutics Inc | 93.2M | -1.2x | --- |
Citius Pharmaceuticals Inc | 94.0M | -2.1x | --- |
InflaRx NV | 84.2M | -1.8x | --- |
Hillevax Inc | 91.1M | -0.5x | --- |
Tiziana Life Sciences Ltd | 95.3M | -5.9x | --- |
Renovaro Inc | 96.6M | -0.5x | --- |
Company Information
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders. The Company’s lead program, REL-1017, is a NCE and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 is in late-stage development as an adjunctive treatment for MDD in adults. Its esmethadone, is being developed as a rapidly acting, oral agent for the treatment of depression and other potential indications.
Contact Information
- Headquarters
- 2222 Ponce De Leon Blvd. 3Rd FloorCORAL GABLES, FL, United States 33134
- Phone
- 646-876-3459
- Fax
- ---
Executives
- Independent Chairman of the Board
- Charles Casamento
- Chief Executive Officer, Director
- Sergio Traversa
- Chief Financial Officer
- Maged Shenouda
- Chief Accounting, Compliance Officer
- Charles Ence
- Acting Chief Scientific Officer
- Paolo Manfredi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $93.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 30.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.51 |
EPS | $-2.88 |
Book Value | $2.84 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
